Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!
Visit our Twitter page for real-time updates, click here: Penny Stock Experts
Hi Everyone & Welcome New Subscribers,
GW Pharmaceuticals plc (GWPH) announced positive results this morning from a Phase 3 study of their cannabis drug Epidiolex® for the treatment Dravet syndrome, a rare and severe form of epilepsy in children, which resulted in a dramatic decrease in convulsive seizures assessed over the treatment period compared with placebo.
Read the entire press release on the company’s website, HERE.
Shares of GWPH opened up 100% over the previous close, and held to close up 120% on the day.
As a result of today’s exciting news for GWPH, several small cap stocks caught a boost of momentum, which has been the first sign of a sector wide move for cannabis related stocks in quite some time.
Among the most impressive were CBDS (Cannabis Sativa) which closed up more than 240% on the day, with all time record volume, at 1.535 per share, just off it’s session high of 1.60 at the close.
CANV (CannaVest Corp.) also made a very nice move today, adding to it’s already impressive 100% move over the past couple weeks, closing up more than 75% at .658, not far from the session high of .675.
Other notable moves in the sector include GRNH (GreenGro Technologies, Inc.) +53.74%, CBIS (Cannabis Science Inc.) 48.11%, and HEMP (Hemp, Inc.) +25.00%.
Keep a close eye on the entire cannabis sector tomorrow!
Sign up-> NOW <-To Join Our E-mail List!
Please read our legal Disclaimer below:
Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.
We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.
Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.
To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.